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In 1981 over one billion dollars will be spent
sustaining the lives ofpatients with end-stage renal
disease by hemodialysis and renal transplantation,
but less than 0.02% ofthis amount will be invested
in studies of nephrotoxicity (1). Any knowledge of
the effect of industrial waste on human kidney
disease gained from this miniscule effort will prob-
ably be serendipitous. Our monumental ignorance
ofthis subject appears to have two sources. First,
research on nephrotoxicity is largely confined to
acute, high-dose exposure in animals; the delayed
effects ofchronic low-dose exposure in man remain
virtually unexplored. Second, the etiology of most
chronic kidney diseases in man is unknown. The
diagnostic categories commonly used for end-stage
renal diseases rarely stipulate underlying causes.
Roughly 60% of dialysis and transplant patients
are reported to have glomerulonephritis orintersti-
tial nephritis. These two entities encompass most
acquired chronic renal diseases. Yet methods for
determining etiology are rudimentary, arbitrary or
applicable only in a few highly specialized research
laboratories. In addition, the standard clinical tech-
niques for detecting renal disease, irrespective of
etiology, have been improved little in sensitivity or
specificity since they were described by Richard
Bright 150 years ago. Chronicglomerulonephritis is
usually detected by the presence of albuminuria,
while renal failure is detected by elevations of the
blood urea nitrogen (BUN) or serum creatinine
(Scr). Unfortunately, proteinuria is characteristi-
cally absent in the early phases of interstitial
nephritis and azotemia is not apparent until more
than two-thirds of kidney function is lost. Conse-
quently, toxin-induced chronic interstitial nephritis
which is characterized in its early phases by the
absence of albuminuria cannot usually be detected
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until the disease has become advanced. As the end
stage is approached, etiologic differentiation is
confounded by the long interval between renal
insult and clinical manifestations. The final common
pathway ofrenal disease is similarregardless ofthe
underlying cause. The problems of early detection
ofrenal dysfunction and the determination ofetiol-
ogy must be resolved before progress can be
expected inunravelingthe impact ofenvironmental
toxins on the kidneys.
The list of substances known to be toxic to the
kidneys is enormous. It is also incomplete and
provides only a very crude guide for evaluating the
chronic renal effects oftoxic wastes. Virtually any
substance introduced into the body in sufficient
quantities willproduce acuterenalfailure. Itshould
be remembered thatthe kidneyreceives almost one
quarter of the cardiac output. In performing its
major functions of controlling salt and water bal-
ance and eliminating biological wastes while con-
serving essential constituents of blood, the kidney
concentrates toxic materials in its cells and intra-
tubular fluid. In addition, the kidney metabolizes
many toxic substances sometimes producing toxic
degradation products. Because the concentrations
of toxins may be several hundred times greater in
the kidney than elsewhere, blood concentrations
which are harmless to other tissues may herald
renal damage.
Epidemiologic studies limited to the measure-
ment of Scr and urinary protein are not likely to
provide compellinginformation ontheroleofspecific
nephrotoxins in renal disease. In-depth, long-term
studies of more subtle renal dysfunction will surely
be required for this purpose. Fundamental to such
studies is the quantitation of glomerular filtration
rate (GFR) using clearance techniques. Short cuts
for assessing GFR by the use of the serum creati-
nine, endogenous creatinine clearance or single
dose blood disappearance curves sacrifice accuracy
for convenience and may be misleading. Many
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renal tubular transport functions which, however,
may be present only transiently in the course of
exposure. Such tubular defects must be studied by
cumbersome physiologic techniques if characteris-
tic patterns are to be identified. Examples of such
renal dysfunctions are the aminoaciduria in child-
hood lead poisoning, ,32-microglobulin excretion in
cadmium nephropathy and renal tubular acidosis in
toluene poisoning.
Studies will have to be undertaken in the early
stages of disease and followed over many years if
cause and effect relationships are to be established
with confidence. Once azotemia supervenes, the
problem ofidentifying appropriate control subjects
becomes particularly challenging. Compilation of
data on control renal failure subjects in whom prior
exposure and etiology of renal disease is unknown
is unlikely to illuminate the problem. Control data
mustbecollectedwiththesamemeticulous approach
used in the study of specific disease entities. If
characteristic nephrotoxic effects ofindividual tox-
ins are to be identified, functional data will have to
be corrected for such factors as the state of
hydration, glomerular filtration rate, proteinuria
and osmotic clearance. A lesserundertaking will be
unconvincing because useful data will have been
discarded. There are no quick solutions in sight for
understanding the pathophysiology and pathogene-
sis of kidney disease.
Animal models are essential for the full elucida-
tion of toxic nephropathy. Their interpolation in
terms of human disease is, however, frought with
difficulties. After decades of intensive study of
normal renal function, renal physiologists have
begun to attack the problem of acute high-dose
nephrotoxicity. The time is now ripe for gaining
insight into chronic, low-dose nephrotoxicity but
for this purpose research grants longer than five
years duration will have to be awarded.
Assessment of past toxic exposure is at least as
difficult as determining the etiology of renal dis-
ease. The outlook for determining body content of
industrial wastes is brightened by the potential
application of modern physics technology to the
detection of trace metals and of modern chemical
technologyformeasuringorganiccompounds. Blood
and urine measurements have been the mainstay of
clinical chemistry for two centuries. Despite long
tradition and great convenience, such measure-
ments appear to be of limited value in the assess-
ment of cumulative exposure for many substances
with toxic potential. On the other hand, X-ray-
induced fluorescence for detection of bone lead
stores and neutron activation analysis for detection
ofrenal cadmium content appear ready for exploi-
tation. The importance of photon and particle
accelerators for the measurement oftrace elements
intissue specimens invitro as well as invivo cannot
be overestimated (2). Electron microscopy may
well take on the musty aura oftraditional anatomy
as advanced particle accelerators define the ele-
mentalcomposition ofintracellularorganelles. Trace
metal measurements at the whole body and subcel-
lular level provide some of the most promising
prospects for understanding the effects of waste
products on the kidney in the near future. Nuclear
magneticresonance, chromatographycombinedwith
mass spectroscopy and selective tissue electrodes
arejust cominginto their own as tools forbiological
research.
For many toxic substances, however, practical
assessment ofpast exposure may not be feasible by
direct measurement. A threshold effect may prove
elusive if cellular damage is cumulative, but the
toxin is not retained. When appropriate tissue
samples are inaccessible or when the offending
agent is no longer present, biologic evidence ofpast
exposure must sometimes be obtained by indirect
measurements ofmetabolic consequences. Anexam-
ple ofa biologic consequence oftoxicity which may
be useful for detecting toxin exposure is 6-p3-hy-
droxycortisol excretion. This adrenocortical metab-
olite has been reported to be increased following
dioxan exposure and decreased following lead ex-
posure. Such indirect approaches may be particu-
larly important for identifying the biologic con-
sequencesofvastnumbers oforganicchemicals pro-
duced by industry. Nevertheless, immediate pros-
pects for establishing etiologic significance of or-
ganic pollutants including pesticides are less prom-
ising than are the prospects for establishing heavy
metal toxicity.
Since many ofthe foregoing generalizations arise
from my personal experience with lead nephropa-
thy over the past decade, it may be worthwhile to
review some ofthe specific lessons. Forpurposes of
this discussion I will not reiterate the clinical data
we have collected or try to persuade you of the
validity ofour conclusions. Rather, I will askyou to
suspend disbelief for a moment, accept our conclu-
sions and contemplate how such clinical observa-
tions might have been overlooked for so long a
time. Very briefly, our studies show that lead
nephropathy is common among asymptomatic work-
ers occupationally exposed to lead (3). Further-
more, lead appears to contribute to the renal
disease encountered in gout patients and usually
termed "gouty nephropathy" (4). Finally, our stud-
ies suggest that lead may explain the occurrence of
renal failure in many hypertensive patients usually
thought to have "essential" hypertension (5). These
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conclusions were derived primarily fromthe EDTA
(CaNa2 edetate) lead mobilization test. Mobilizable
lead was increased in the vast majority of asymp-
tomatic lead workers, as well as in persons with
gout and hypertensive patients with renal failure.
This provocative chelation test made diagnosis
possible. None ofour patients had overt symptoms
of lead intoxication, none had elevated blood or
urine lead concentrations by prevalent standards
and heme synthesis measurements fell within nor-
mal limits at the time of clinical examination.
Unlike the gout and hypertensive patients, the men
with occupational lead nephropathy had no clinical
evidence of renal disease such as proteinuria or
azotemia. Reductions of30-50% in GFR were found
in these lead workers by measurement of125I-iotha-
lamate clearance, a lengthy research laboratory
procedure. The restoration ofrenalfunctiontowards
normal by long-term low-dose EDTA therapy in
four of eight lead workers confirmed the etiologic
diagnosis and attested to the efficacy and safety of
the EDTA treatment.
The relevant lessons from these studies are, I
think, asfollows: (1)textbookdescriptions ofchronic
poisoning do not provide criteria for the diagnosis
of subelinical toxicity; (2) blood and urine measure-
ments are often inadequate for assessment of
chronic exposure; (3) prevention and treatment
cannot be instituted until pathogenesis is under-
stood. Finally, early nonglomerular renal disease
cannot be found by measuring proteinuria and
serum creatinine. There is another lesson which, I
am afraid, is of considerable relevance to a sympo-
sium on research needs: apart from the Veterans
Administration Research Service, no other federal
agency would support this work nor would any one
of several private foundations. Review committees
from the NIH, NIOSH, EPA and NSF have
repeatedly rejected proposals for lead studies pre-
pared from a variety of points of view by a variety
of investigators. Not only is the funding bureau-
cracy (of which I am a sometimes member) unwill-
ing totake risks, but they are reluctant orunable to
cross traditional research lines.
It may be noteworthy that despite the Veterans
Administration's support oflead nephropathy stud-
ies over the past two decades, the VA has received
little recognition forits contributions in this field. A
recent National Academy of Science report on
government sponsored lead research identifies the
Veterans Administration among those agencies not
engaged in significantresearch inlead. I aminclined
to agree with Clair Pattersons's minority opinion
included in the NAS report (6), which can be
paraphrased as follows: it is precisely the obscurity
ofthe VA endeavor that has permitted this agency
to support research that does not simply confirm
preexisting concepts.
Despite the limited resources devoted to under-
standing the effect of environmental toxins on the
kidney, some promising insights have been gained
in the last decade. Surprising interactions between
metals (7) and between organic compounds and
metals (8) have been found when experiments were
designed to elucidate such complexities. It has
recently been shown that certain organic pollutants
sensitize the kidney to the toxic effects of other
organic compounds. Kluwe and Hook (9) at the
NIEHS have made major strides in clarifying the
nephrotoxic interactions of several organic com-
pounds in animal models. They have recently dem-
onstrated in rats, for example, that increased renal
susceptibility to toxins is transmitted to pups in
maternal milk by dams fed polybrominated biphe-
nyls (10).
The study of the effects of toxic wastes is
necessarilymultidisciplinary. Theglomerulonephri-
tis and interstitial nephritis induced by chronic
low-dose exposure to toxic agents may be im-
munologicallymediated. Epidemiologic studieshave
provided suggestive evidence that solvent fumes
increase susceptibility to the development of glo-
merulonephritis in man (11). Although these con-
clusions are based entirely on historical information
recalled by patients, the hypothesis warrants care-
ful prospective evaluation in the industrial setting
and animal research laboratory. Immunologic medi-
ation has been more clearly demonstrated in stud-
ies of mercury-induced glomerulonephritis in rats
by Druet and his associates in France (12). Their
work suggests that mercuric chloride elicits glo-
merular immune disease by effects on immunocom-
petent lymphocytes rather than by modification of
endogenous antigens. Glomerular disease due to
mercury may therefore be unrelated to the mer-
cury content of the kidney in contrast to acute
tubular necrosis which is dependent on cellular
accumulation ofthe toxic metal. This rat model may
have important implications for the pathogenesis of
mercury-induced proteinuria in man. The sporadic
appearance ofnephrotic syndrome induced by envi-
ronmental toxins will not, however, meet Koch's
postulates until our knowledge of immunogenetics
is greatly refined.
The answers to most questions about environ-
mental nephrotoxins are dependent upon advances
in basic biology and technology. Crucial stepping
stones will, in my opinion, come from studies of
membrane structure and function, immunology,
genetics, metabolism and cell biology. While await-
ing these developments we must exploit available
techniques ofrenal physiology and applied physics.
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Concensus is appropriate for political decision-
making when inadequate information is available,
but public confidence in the face of ignorance is
fragile. In some ways, the media handling of toxic
waste issues reminds me of the medieval response
to plague and leprosy-in the absence of the
necessary facts, the public's energy is directed
towards exorcising the devil. Sound information is
a constructive way to dissipate fear of an environ-
ment that is perceived to be out of control. Such
information will not be easy or inexpensive to
acquire. Economic constraints demand that the
effort be highly selective. Research at its best is
opportunistic -effort must be placed inthose areas
which current technology and knowledge have
ripened for fruitful investigation. The questions to
attack are not just those that are of most public
concern but those that contemporary methodology
can resolve. We are likely to be overwhelmed with
the expense of such "intermediate technologies" as
dialysis and transplantation until we are willing to
invest sufficient resources in research to make
preventive nephrology a reality.
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